ENTX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

ENTXEntera Bio Ltd.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

ENTXEntera Bio Ltd.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ENTXEntera Bio Ltd.

3.06▼−1.02%· post 3.06

Mkt cap$153.9MRevenue$42,000Q1 FY25Revenue—

AMGNAmgen Inc

460.67▼−1.03%· post 456.16

ClosedNov 3 '26

Mkt cap$249.4BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

ClosedNov 3 '26

ENTXEntera Bio Ltd.

AMGNAmgen Inc

3.06▼−1.02%post 3.06

Price

460.67▼−1.03%post 456.16

$153.9M

Mkt cap

$249.4B

Q1 FY25$42,000

Revenue

$10.1BQ2 FY26

—

Revenue

$36.8BFY25

ENTX3.06▼−1.02%vsAMGN460.67▼−1.03%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ENTX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ENTX 1

OPKOPKO Healthsupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customerSource: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

ENTX, solidAMGN, dashed